Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and Progress

Area of Science:

• Ophthalmology and genetics
• Retinal disease research

Background:

• Acquired retinal diseases, including age-related macular degeneration and diabetic retinopathy, are leading causes of vision loss globally.
• Current treatments face challenges with high treatment burden and poor patient compliance, impacting real-world effectiveness.

Purpose of the Study:

• To explore the potential of gene-based therapeutics for acquired retinal diseases.
• To review current progress, challenges, and future directions in this field.

Main Methods:

• Review of existing literature on gene-based therapeutic strategies for acquired retinal diseases.
• Analysis of gene augmentation and gene editing approaches.
• Evaluation of surgical delivery techniques and their limitations.

Main Results:

• Gene-based therapeutics present advantages for acquired retinal diseases, including defined targets and broader applicability compared to inherited retinal diseases.
• Gene augmentation and gene editing are being investigated as methods to deliver therapeutic molecules or modulate disease pathways.
• Progress has been made in therapeutic strategies and delivery methods, though limitations remain.

Conclusions:

• Gene-based therapeutics hold significant promise for addressing unmet needs in acquired retinal diseases.
• Further research and development are crucial to overcome current limitations and optimize treatment strategies for improved patient outcomes.